Altium Wealth Management LLC Alaunos Therapeutics, Inc. Transaction History
Altium Wealth Management LLC
- $1.39 Billion
- Q2 2022
A detailed history of Altium Wealth Management LLC transactions in Alaunos Therapeutics, Inc. stock. As of the latest transaction made, Altium Wealth Management LLC holds 15,000 shares of TCRT stock, worth $10,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000
Previous 15,000
-0.0%
Holding current value
$10,500
Previous $10,000
90.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TCRT
# of Institutions
8Shares Held
106KCall Options Held
0Put Options Held
0-
Gamble Jones Investment Counsel61KShares$42,7000.0% of portfolio
-
Sawtooth Solutions, LLC14.3KShares$9,9750.0% of portfolio
-
Argi Investment Services, LLC13KShares$9,1000.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.1KShares$1,4700.0% of portfolio
-
Trustcore Financial Services, LLC250Shares$1750.0% of portfolio
About Alaunos Therapeutics, Inc.
- Ticker TCRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,182,000
- Market Cap $151M
- Description
- Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...